Filing Details

Accession Number:
0000899243-18-016282
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-12 20:22:23
Reporting Period:
2018-06-08
Accepted Time:
2018-06-12 20:22:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1160308 Savara Inc SVRA Pharmaceutical Preparations (2834) 841318182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1703641 Taneli Jaakko Jouhikainen 6836 Bee Cave Road, Building Iii
Suite 200
Austin TX 78746
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-06-08 2,638 $12.11 207,688 No 4 S Direct
Common Stock Disposition 2018-06-11 1,625 $12.02 206,063 No 4 S Direct
Common Stock Disposition 2018-06-12 13,494 $12.10 192,569 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.
  2. The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.55. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  3. The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.14. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.225. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.